Cytovance Biologics vs Pharmaron Biologics: CDMO Comparison
How does Cytovance Biologics compare to Pharmaron Biologics for Plasmid DNA manufacturing?
Side-by-side comparison of Cytovance Biologics and Pharmaron Biologics on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
On a 13-modality CDMO landscape, both Cytovance Biologics and Pharmaron Biologics qualify as Plasmid DNA manufacturers; Pharmaron Biologics carries the higher composite Signal Score for Plasmid DNA programs in this comparison.
What to evaluate for Plasmid DNA programs
Both Cytovance Biologics and Pharmaron Biologics qualify as Plasmid DNA CDMOs. When choosing between them for Plasmid DNA programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
GMP grade & purity
Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality.
Fermentation scale & yield
Match fermentation scale and yield to your vector or mRNA demand. Ask about high-yield strains and whether scale-up is validated.
Lead time
Plasmid is a common critical-path bottleneck. Evaluate realistic queue and turnaround against your program timeline.
Regulatory track record
Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.
Frequently asked: Cytovance Biologics vs Pharmaron Biologics
How does Cytovance Biologics compare to Pharmaron Biologics for Plasmid DNA manufacturing?
On CDMO Signal's composite Signal Score, Cytovance Biologics is 79/100 and Pharmaron Biologics is 87/100; Cytovance Biologics has 1 FDA inspection on record vs 3 for Pharmaron Biologics. Both are tracked in the CDMO Signal directory as Plasmid DNA CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, Cytovance Biologics or Pharmaron Biologics?
Both Cytovance Biologics and Pharmaron Biologics maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Cytovance Biologics has 1 FDA inspection on record; Pharmaron Biologics has 3.
Which is better for Plasmid DNA manufacturing — Cytovance Biologics or Pharmaron Biologics?
Both Cytovance Biologics and Pharmaron Biologics are tagged as Plasmid DNA CDMOs in our directory, so both are credible options for Plasmid DNA programs. The most important differentiator for Plasmid DNA selection is typically gmp grade & purity: Confirm GMP (vs research/HQ) grade, supercoiled percentage, and residual host-cell DNA/RNA and endotoxin specs — these gate downstream vector and mRNA quality. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Cytovance Biologics carries a Signal Score of 79/100 and Pharmaron Biologics carries 87/100 — a small lead for Pharmaron Biologics. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →